Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,650 | 2 | 90.3% |
| Food and Beverage | $1,140 | 42 | 9.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Skye Orthobiologics LLC | $10,650 | 2 | $0 (2024) |
| Smith+Nephew, Inc. | $621.19 | 22 | $0 (2024) |
| Kerecis Limited | $156.19 | 4 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $55.37 | 3 | $0 (2022) |
| Stryker Corporation | $48.77 | 1 | $0 (2022) |
| Crossroads Orthopedics, LLC | $40.41 | 1 | $0 (2021) |
| AbbVie Inc. | $39.34 | 2 | $0 (2023) |
| ConvaTec Inc. | $36.96 | 2 | $0 (2024) |
| Misonix Inc | $31.65 | 2 | $0 (2021) |
| Melinta Therapeutics, LLC | $31.31 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,176 | 8 | Skye Orthobiologics LLC ($3,000) |
| 2023 | $7,853 | 7 | Skye Orthobiologics LLC ($7,650) |
| 2022 | $330.19 | 16 | Smith+Nephew, Inc. ($169.62) |
| 2021 | $278.18 | 11 | Smith+Nephew, Inc. ($173.20) |
| 2020 | $152.81 | 2 | Smith+Nephew, Inc. ($152.81) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Wound Care | ||||||
| 10/03/2024 | Urgo Medical North America, LLC | URGOK2 (Device), VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: COMPRESSION | ||||||
| 08/14/2024 | Solventum Corporation | ACTIV.A.C. (Device) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 06/28/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 06/06/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX | Food and Beverage | In-kind items and services | $35.42 | General |
| Category: Other Advanced Wound Management | ||||||
| 02/29/2024 | Smith+Nephew, Inc. | ACTICOAT 4" X 4" (Device), PICO, RENASYS TOUCH | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Infection Management | ||||||
| 02/01/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $44.08 | General |
| Category: Wound Care | ||||||
| 01/05/2024 | Skye Orthobiologics LLC | — | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: Surigcal Evaluations | ||||||
| 12/31/2023 | Skye Orthobiologics LLC | — | — | Cash or cash equivalent | $7,650.00 | Research |
| Study: Surigcal Evaluations | ||||||
| 09/18/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $81.62 | General |
| Category: Wound Care | ||||||
| 08/17/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: ANTIBIOTICS | ||||||
| 08/03/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2023 | Smith+Nephew, Inc. | PICO 7 (Device), RENASYS TOUCH | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 03/16/2023 | Smith+Nephew, Inc. | GRAFIX (Medical Supply), STRAVIX | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Other Advanced Wound Management | ||||||
| 01/19/2023 | Smith+Nephew, Inc. | GRAFIX (Medical Supply) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Other Advanced Wound Management | ||||||
| 12/02/2022 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Pharma Products | ||||||
| 10/10/2022 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: Extremities & Limb Restoration | ||||||
| 09/12/2022 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Extremities & Limb Restoration | ||||||
| 08/25/2022 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Wound Care | ||||||
| 08/18/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: ANTIBIOTIC | ||||||
| 07/20/2022 | Stryker Corporation | ORTHOLOC 2 LAPIFUSE (Device) | Food and Beverage | In-kind items and services | $48.77 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 05/19/2022 | Smith+Nephew, Inc. | PICO (Device) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 04/28/2022 | Smith+Nephew, Inc. | Iodosorb Ointment 40g USA (Device), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Infection Management | ||||||
| 04/14/2022 | ConvaTec Inc. | CONVATEC INC. (Medical Supply), AQUACEL AG+ | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 04/14/2022 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Other Advanced Wound Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Surigcal Evaluations | Skye Orthobiologics LLC | $10,650 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 279 | 588 | $79,933 | $23,618 |
| 2022 | 5 | 213 | 461 | $58,036 | $21,522 |
| 2021 | 3 | 73 | 117 | $20,500 | $7,215 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 224 | $38,045 | $12,878 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $17,050 | $4,583 | 26.9% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 18 | 84 | $15,120 | $3,358 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 26 | $4,550 | $1,241 | 27.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 17 | $2,550 | $974.78 | 38.2% |
| 64455 | Injection of anesthetic and/or steroid drug into foot nerve | Office | 2023 | 15 | 15 | $1,875 | $537.84 | 28.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 47 | $470.00 | $36.98 | 7.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 109 | $272.50 | $9.02 | 3.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 143 | $20,306 | $9,065 | 44.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $15,540 | $5,557 | 35.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 22 | 44 | $7,920 | $4,056 | 51.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 17 | 75 | $13,500 | $2,800 | 20.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 61 | $610.00 | $39.30 | 6.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 64 | $160.00 | $4.31 | 2.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 40 | $5,680 | $2,760 | 48.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $6,720 | $2,501 | 37.2% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 11 | 45 | $8,100 | $1,955 | 24.1% |
About Joseph Candela
Joseph Candela is a Foot & Ankle Surgery healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1225526676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Candela has received a total of $11,790 in payments from pharmaceutical and medical device companies, with $3,176 received in 2024. These payments were reported across 44 transactions from 14 companies. The most common payment nature is "" ($10,650).
As a Medicare-enrolled provider, Candela has provided services to 565 Medicare beneficiaries, totaling 1,166 services with total Medicare billing of $52,355. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Foot & Ankle Surgery
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Shelbyville, IN
- Active Since 05/01/2018
- Last Updated 04/21/2021
- Taxonomy Code 213ES0103X
- Entity Type Individual
- NPI Number 1225526676
Products in Payments
- STRAVIX (Medical Supply) $198.12
- Kerecis Omega3 SurgiClose (Device) $156.19
- STRAVIX (Biological) $85.83
- GRAFIX PL (Biological) $66.98
- GRAFIX PL (Medical Supply) $56.56
- NUZYRA (Drug) $55.37
- GRAFIX (Medical Supply) $52.30
- ORTHOLOC 2 LAPIFUSE (Device) $48.77
- ACTIV.A.C. (Device) $40.56
- DALVANCE (Drug) $39.34
- OASIS (Device) $33.57
- PICO7 (Device) $32.26
- Kimyrsa (Drug) $31.31
- INNOVAMATRIX AC (Device) $21.31
- ACTICOAT 4" X 4" (Device) $21.13
- URGOK2 (Device) $20.28
- Hammerlock (Device) $17.71
- COLLAGENASE SANTYL (Drug) $16.82
- PICO 7 (Device) $16.71
- REGRANEX (Drug) $16.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.